Deck
Shakti Pumps is India's largest solar pump exporter and the lead beneficiary of the PM-KUSUM agricultural-solar scheme, supplying state tenders alongside a 100-country export book and a new ₹1,200 Cr captive solar-cell plant.
Bull and bear agree on the facts. They disagree on whether 24% EBITDA was the floor or the peak.
- The accrual story. Revenue 1.8×'d FY24→FY25 to ₹2,516 Cr; operating margin hit a record 24%; ROCE printed 55%. Two clean QIPs (₹200 Cr in 2024 at ₹1,208, ₹293 Cr in 2025) erased net debt before the SESL build. Promoters bought ₹7 Cr across six trades through the drawdown — including Vintex Tools at ₹116 in February 2026 — and sold zero.
- The cash story. Three years of work produced ₹808 Cr of cumulative PAT and ₹194 Cr of CFO — a 24% conversion ratio. FY25 alone: ₹408 Cr profit on ₹20 Cr operating cash. DSO peaked near 190 days as PM-KUSUM receivables ballooned to ₹1,639 Cr — almost six months of revenue.
- The reset. Q4 FY26 op margin collapsed to 9.7%; PAT down 65% YoY on record ₹858 Cr revenue. Management's margin guide misses run 4-of-5: 24% guided, 16% delivered FY26. Stock at ₹550 is down 59% from January 2025.
Cycle peak is in the rear-view; the capex commitment is still in front.
₹1,200 Cr is committed to a 2.2 GW captive solar-cell plant at SESL — 4× Oswal's commissioned 0.57 GW — to defend gross margin as PLI-funded Indian cell capacity scales from 13 GW to 50–55 GW by FY27. The full plant has slipped to H1 FY27. Q4 FY26 collected ₹420 Cr of receivables back, lifting FY26 CFO to ₹124 Cr from ₹20 Cr — encouraging, but the test repeats every quarter from here.
An auditor change, a related-party plant audit, and a board that thinned out at the wrong time.
- Auditor swap dated 7 May 2026. Filed the same day as the Q4 FY26 PAT collapse. The FY26 statutory audit report is due on or before 30 May. Routine SEBI rotation is neutral; a non-routine resignation reframes the entire governance read in one filing.
- Related-party audit at SESL. The ₹1,200 Cr Shakti Energy Solutions plant — the company's largest capital allocation in 13 years — is audited by 'S.B. Patidar & Co.' The surname matches the controlling family. SESL is not classified as a related party in disclosures.
- Board churn at the audit committee. Three audit chairs in FY25; the current chair, appointed 20 March 2025, missed every FY25 meeting. The Risk Committee is chaired by the MD himself. Average independent-director tenure: 1.4 years. The latest QIP monitoring report flags ₹1,043 Mn unutilised.
Half the open questions resolve in dated, observable events between now and August.
- 11 May 2026 — Q4 conference call. First chance for management to explain the auditor change and the 9.7% margin print on the same line. Highest-impact single-day event in the calendar.
- ≤30 May — FY26 audit report. Clean opinion vs qualified is binary on the bear's primary trigger. A clean report removes the largest overhang in one filing; a modification would force estimates and confidence to reset.
- Aug 2026 — Q1 FY27 print + SESL commissioning. Both sides agree the threshold is CFO/PBT > 0.7× with DSO < 150. The first 0.5 GW DCR cell line targets Q1 FY27; the full 2.2 GW has slipped to H1 FY27, with some statements pointing to March 2027.
From asset-light pump assembler to vertically-integrated solar PV manufacturer in three quarters.
Before: A century-old industrial pump maker (incorporated 1995, brand since 1982) trading under ₹50 for two decades; PM-KUSUM lifted the cycle from FY21 onward as the company won the highest share in agricultural solar tenders.
Pivot: Q3 FY25 — management cited DCR solar-cell shortage as the binding constraint and announced the ₹1,200 Cr 2.2 GW SESL plant, taking integration from 4-of-5 layers to 5-of-5 and adding commodity-cell risk to the balance sheet.
Today: Q3 FY26 broke the narrative — PAT down 69% YoY, op margin halved to 11%, stock −14% intraday on a 'deliberate slowdown' framing. The next chapter answers whether SESL ramps before Indian cell capacity quadruples and commoditises the arbitrage.
Lean cautious — the next 60 days do most of the work for both sides.
- For. Cycle trough may already be in the print: stock −59% from peak, FY26 EPS of ₹20.87 already reflects the margin halving, Q4 collected ₹420 Cr of receivables back. Promoters bought ₹7 Cr at the trough — six trades, zero sells.
- For. SESL captive cell plant (2.2 GW, ₹1,200 Cr) takes integration to 5-of-5 layers; bull case adds 200–300 bps to a 15–16% margin guide. Diversified 100-country export book grew at a 25% CAGR through FY21–25 and now contributes 17% of revenue.
- Against. A moat that produced ₹408 Cr of accrual profit on ₹20 Cr of cash at the cycle peak isn't earning its keep. L1 reverse auction plus Indian cell capacity going from 13 GW to 50–55 GW by FY27 commoditises the SESL arbitrage in the same window it ramps. Oswal already prints higher op margin (29% vs 24%) and higher PM-KUSUM share (38% vs 25%).
- Against. Auditor change on 7 May, audit report due ≤30 May, related-party plant audit at the controlling family's namesake firm, ₹1,043 Mn QIP cash unutilised. The trust overhang sits behind events that resolve fast.
Watchlist to re-rate: Auditor's opinion on the FY26 report (≤30 May 2026); SESL Q1 FY27 commissioning utilisation; CFO/PBT and DSO trajectory in the next two quarterly prints.